CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
-1.39%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$345M
AUM Growth
+$21M
(+6.5%)
Cap. Flow
+$33M
Cap. Flow
% of AUM
9.58%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
466
New
14
Increased
365
Reduced
39
Closed
20
Top Buys
| 1 |
Amazon
AMZN
|
$3.98M |
| 2 |
Procter & Gamble
PG
|
$3.03M |
| 3 |
Booking.com
BKNG
|
$2.86M |
| 4 |
Apple
AAPL
|
$2.77M |
| 5 |
SPDR Gold MiniShares Trust
GLDM
|
$2.63M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$3.25M |
| 2 |
TSMC
TSM
|
$3.11M |
| 3 |
Carnival Corp
CCL
|
$2.64M |
| 4 |
On Holding
ONON
|
$2.57M |
| 5 |
Advanced Micro Devices
AMD
|
$2.07M |
Sector Composition
| 1 | Technology | 38.24% |
| 2 | Consumer Discretionary | 20.57% |
| 3 | Healthcare | 19.52% |
| 4 | Communication Services | 8.19% |
| 5 | Consumer Staples | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Acadia Pharmaceuticals
ACAD
$4.26B
| $87.6K | 0.03% |
4,202
+2,070
| +97% | +$43.1K |
|
202
eBay
EBAY
$42.3B
| $87.4K | 0.03% |
1,983
+1,380
| +229% | +$60.8K |
|
203
Dollar Tree
DLTR
$20.6B
| $87.3K | 0.03% |
820
-5,054
| -86% | -$538K |
|
204
Zscaler
ZS
$42.7B
| $84.6K | 0.02% |
544
+380
| +232% | +$59.1K |
|
205
Amphenol
APH
$135B
| $84.2K | 0.02% |
2,000
| – | – |
|
206
Axsome Therapeutics
AXSM
$6.25B
| $84.1K | 0.02% |
1,204
+633
| +111% | +$44.2K |
|
207
Krystal Biotech
KRYS
$4.35B
| $83.3K | 0.02% |
718
+379
| +112% | +$44K |
|
|
BPMC
208
DELISTED
Blueprint Medicines
BPMC
| $77.8K | 0.02% |
1,550
+757
| +95% | +$38K |
|
209
New Oriental
EDU
$7.98B
| $77.6K | 0.02% |
1,325
| – | – |
|
210
Revolution Medicines
RVMD
$7.57B
| $77.6K | 0.02% |
2,802
+1,409
| +101% | +$39K |
|
|
MRTX
211
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $76.3K | 0.02% |
1,752
+990
| +130% | +$43.1K |
|
212
Arrowhead Research
ARWR
$4.02B
| $74K | 0.02% |
2,753
+1,352
| +97% | +$36.3K |
|
213
Denali Therapeutics
DNLI
$2.26B
| $72.7K | 0.02% |
3,526
+1,732
| +97% | +$35.7K |
|
214
Cytokinetics
CYTK
$6.34B
| $72.6K | 0.02% |
2,463
+1,209
| +96% | +$35.6K |
|
215
Akero Therapeutics
AKRO
$3.58B
| $72.1K | 0.02% |
1,426
+701
| +97% | +$35.5K |
|
216
Intellia Therapeutics
NTLA
$1.29B
| $71.6K | 0.02% |
2,263
+1,108
| +96% | +$35K |
|
|
WBA
217
DELISTED
Walgreens Boots Alliance
WBA
| $71.5K | 0.02% |
3,217
+2,243
| +230% | +$49.9K |
|
218
Structure Therapeutics
GPCR
$1.27B
| $71.1K | 0.02% |
1,410
-25,857
| -95% | -$1.3M |
|
219
Madrigal Pharmaceuticals
MDGL
$9.65B
| $68.3K | 0.02% |
468
+228
| +95% | +$33.3K |
|
220
Tencent Music
TME
$37.7B
| $66.4K | 0.02% |
+10,400
| New | +$66.4K |
|
221
Prothena Corp
PRTA
$460M
| $66.3K | 0.02% |
1,375
+684
| +99% | +$33K |
|
222
Ultragenyx Pharmaceutical
RARE
$3.07B
| $65.3K | 0.02% |
1,831
+903
| +97% | +$32.2K |
|
223
SiriusXM
SIRI
$8.1B
| $64.7K | 0.02% |
1,432
+995
| +228% | +$45K |
|
224
Enphase Energy
ENPH
$5.18B
| $61K | 0.02% |
508
+353
| +228% | +$42.4K |
|
225
Nuvalent
NUVL
$5.83B
| $61K | 0.02% |
1,327
+654
| +97% | +$30.1K |
|